Cite

HARVARD Citation

    Jeay, M. et al. (n.d.). P361 Risk of persistent gastrointestinal inflammation after treatment with immune checkpoint inhibitors. Journal of Crohn's and colitis. p. i494. [Online]. 
  
Back to record